AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Martin Shkreli Ordered to Forfeit $7.36 Million in Assets Ahead of Sentencing March 5, 2018 Little Idorsia Scores $230M+ R&D Deal With Johnson & Johnson December 3, 2017 Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston July 17, 2017